Rock Creek Pharmaceuticals Reports on Inhibition of STAT 3 Activation, A Key Marker of Inflammation, In Phase I Clinical Trial in Europe
Homerun Resources Inc. Announces Receipt of a Competitive Budgetary Offer for Latin America's First Dedicated Solar Glass Manufacturing Facility
